Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
MGRXthis companyMangoceuticals, Inc.	$0.20	-0.34×	0.49×	16.34×	-0.33×	-69.5%	54.9%	-4200.5%	-4526.9%	-135.8%	-123.5%	-78.5%	0.02×	0.06×	-185.05×	1.74×	0.0%	3	-6.14	2	C+
ASBPAspire Biopharma Holdings, Inc.	$8.45	-9.67×	-37.14×	38,181.4×	-20.93×	-107.4%	-1.9%	-312016.9%	-394725.1%	383.9%	395.3%	-2.1%	-0.22×	-0.03×	-2.27×	0.17×	0.0%	5	-3.49	2	C
CINGCingulate Inc.	$4.40	-1.05×	9.4×	0×	-1.1×	-99.0%	0.0%	0.0%	0.0%	-894.8%	-176.5%	-73.8%	3.5×	0.11×	-21.57×	1.16×	0.0%	2	-3.41	2	C
FEMYFemasys Inc.	$1.43	-1.23×	3.88×	9.93×	-1.15×	-203.0%	62.0%	-767.0%	-812.3%	-317.4%	-100.1%	-84.4%	0.8×	0.29×	-9.3×	4.53×	0.0%	1	-18.41	1	D+
HCTIHealthcare Triangle, Inc.	$3.62	-0.25×	0.24×	0.17×	-0.67×	-473269.7%	13.6%	-70.5%	-68.2%	-94.9%	-47.3%	-703.6%	1.08×	-0.38×	-17.26×	1.03×	0.0%	2	-1.43	2	C
PALIPalisade Bio, Inc.	$1.23	-7.83×	1.01×	0×	0.15×	113.1%	0.0%	0.0%	0.0%	-13.0%	-13.9%	-8.3%	0×	7.95×	-1,805.6×	28.95×	0.0%	4	19.43	2	C
Peer median	—	-1.23×	1.01×	0.17×	-1.1×	-107.4%	0.0%	-70.5%	-68.2%	-94.9%	-47.3%	-73.8%	0.8×	0.11×	-17.26×	1.16×	0.0%	2	-3.41	2	—